Home › Immune System and Disorders › Nebraska › Omaha
Immune System and Disorders clinical trials in Omaha, NE
3 studies for Immune System and Disorders are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi away
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- University of Nebraska Medical Center, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- Fred and Pamela Buffett Cancer Center, Omaha
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Boston, MA10 studies
- Philadelphia, PA10 studies
- Atlanta, GA9 studies
- Portland, OR9 studies
- Houston, TX9 studies
- Los Angeles, CA8 studies
- Cleveland, OH8 studies
- Chicago, IL8 studies
- Milwaukee, WI6 studies
- Seattle, WA6 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Colorectal Cancer18 studies
- Cancer (all types)18 studies
- Multiple Myeloma16 studies
- Non-Hodgkin Lymphoma14 studies
- Ovarian Cancer14 studies
- Pancreatic Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
- Metastatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.